Clinical Trial

Tumor-Derived Extracellular Vesicles for Noninvasive Molecular Classification of Kidney Cancer

Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
This is a correlative (lab-based) study aiming to identify protein markers in urine extracellular vesicles (EVs) that can be used to develop non-invasive molecular tests for patients with renal cell carcinoma (RCC). Aim 1 will use urine collected previously in biorepository. Aim 2 will prospectively collect blood specimens pre and post nephrectomy.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2025-11-19; most recent amendment 2026-02-24.
Trial Details
NCT Number NCT07243067
Lead Sponsor Mayo Clinic
Conditions Renal Cell Carcinoma, Clear-cell Renal Cell Carcinoma, Papillary Renal Cell Carcinoma, Chromophobe Renal Cell Carcinoma, Kidney Cancer
Enrollment 300 participants
Start Date 2026-07-15
Primary Completion 2027-04-30 (estimated)
Study Completion 2027-04-30 (estimated)
Updated on ClinicalTrials.gov 2026-02-27